| SAKAR HEALTHCARE  Financial Statement Analysis | ||
| The Revenues of SAKAR HEALTHCARE  have increased by 4.00% YoY . The Earnings Per Share (EPS) of SAKAR HEALTHCARE has decreased by -19.85 % YoY. | ||
| REVENUES | 
| OPERATING MARGIN | 
| PROFIT AFTER TAX | 
| EPS | 
| ROCE | 
SAKAR HEALTHCARE  Last 5 Annual Financial Results
 [NSE : SAKAR] 
            | Consolidated | Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | 
|---|---|---|---|---|---|
| Revenues | ₹133 Cr | ₹128 Cr | ₹95 Cr | ₹8,298,024 Cr | ₹83 Cr | 
| Expenses | ₹100 Cr | ₹99 Cr | ₹72 Cr | ₹6,343,119 Cr | ₹63 Cr | 
| Operating Profit (Excl OI) | ₹33 Cr | ₹29 Cr | ₹23 Cr | ₹1,954,905 Cr | ₹20 Cr | 
| Other Income | ₹4.68 Cr | ₹2.17 Cr | ₹1.18 Cr | ₹201,684 Cr | ₹2.02 Cr | 
| Interest | ₹5.96 Cr | ₹2.91 Cr | ₹2.50 Cr | ₹225,918 Cr | ₹2.26 Cr | 
| Depreciation | ₹15 Cr | ₹9.67 Cr | ₹8.06 Cr | ₹707,981 Cr | ₹7.08 Cr | 
| Profit Before Tax | ₹17 Cr | ₹19 Cr | ₹13 Cr | ₹1,222,691 Cr | ₹12 Cr | 
| Profit After Tax | ₹13 Cr | ₹15 Cr | ₹11 Cr | ₹962,285 Cr | ₹9.62 Cr | 
| Consolidated Net Profit | ₹13 Cr | ₹15 Cr | ₹11 Cr | ₹962,285 Cr | ₹9.62 Cr | 
| Earnings Per Share (Rs) | ₹5.37 | ₹6.70 | ₹8.87 | ₹6.84 | ₹6.43 | 
| PAT Margin (%) | 7.61 | 9.57 | 11.84 | 11.28 | 11.60 | 
| ROE(%) | 5.42 | 8.48 | 13.44 | 11.88 | 11.83 | 
| ROCE(%) | 7.42 | 8.95 | 12.09 | 13.16 | 14.79 | 
| Total Debt/Equity(x) | 0.31 | 0.69 | 0.73 | 0.43 | 0.20 | 
| Key Financials | ||
| Market Cap | : | ₹ 796.6 Cr | 
| Revenue (TTM) | : | ₹ 189.2 Cr | 
| Net Profit(TTM) | : | ₹ 19.8 Cr | 
| EPS (TTM) | : | ₹ 8.9 | 
| P/E (TTM) | : | 40.3 | 
| Industry Peers & Returns | 1W | 1M | 1Y | 
| SAKAR HEALTHCARE | -1.7% | -2.4% | 10.7% | 
| SUN PHARMACEUTICAL INDUSTRIES | 0.3% | 4.1% | -9.9% | 
| DIVIS LABORATORIES | -1.7% | 8.5% | 13.2% | 
| CIPLA | -3.4% | 3% | 4.8% | 
| TORRENT PHARMACEUTICALS | 0.7% | -0.5% | 7.2% | 
| DR REDDYS LABORATORIES | 0.2% | -1.1% | -3.6% | 
| MANKIND PHARMA | -1.6% | -4.5% | -5.3% | 
| ZYDUS LIFESCIENCES | 1.2% | -2.1% | 1.8% | 
| LUPIN | -1.2% | -3.5% | -9.4% | 
SAKAR HEALTHCARE  Revenues
 [NSE : SAKAR]  
                        | Y-o-Y | 4.00 % | 
| 5 Yr CAGR | 12.59 % | 
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2024 | ₹133 Cr | 4.00 | |
| Mar2023 | ₹128 Cr | 35.35 | |
| Mar2022 | ₹95 Cr | -100.00 | |
| Mar2021 | ₹8,298,024 Cr | 9,999,928.87 | |
| Mar2020 | ₹83 Cr | - | |
SAKAR HEALTHCARE  Operating Profit
 [NSE : SAKAR]  
                    | Y-o-Y | 13.39 % | 
| 5 Yr CAGR | 14.21 % | 
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2024 | ₹33 Cr | 13.39 | |
| Mar2023 | ₹29 Cr | 29.75 | |
| Mar2022 | ₹23 Cr | -100.00 | |
| Mar2021 | ₹1,954,905 Cr | 9,999,924.55 | |
| Mar2020 | ₹20 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | 9.00 % | 
| 5 Yr CAGR | 1.43 % | 
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2024 | 24.94% | 9.00 | |
| Mar2023 | 22.88% | -4.15 | |
| Mar2022 | 23.87% | 1.32 | |
| Mar2021 | 23.56% | 0.00 | |
| Mar2020 | 23.56% | - | |
SAKAR HEALTHCARE  Profit After Tax
 [NSE : SAKAR]  
            | Y-o-Y | -15.95 % | 
| 5 Yr CAGR | 7.31 % | 
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2024 | ₹13 Cr | -15.95 | |
| Mar2023 | ₹15 Cr | 42.09 | |
| Mar2022 | ₹11 Cr | -100.00 | |
| Mar2021 | ₹962,285 Cr | 9,999,739.14 | |
| Mar2020 | ₹9.62 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | -20.48 % | 
| 5 Yr CAGR | -10.00 % | 
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2024 | 7.61 % | -20.48 | |
| Mar2023 | 9.57 % | -19.17 | |
| Mar2022 | 11.84 % | 4.96 | |
| Mar2021 | 11.28 % | -2.76 | |
| Mar2020 | 11.6 % | - | |
SAKAR HEALTHCARE  Earnings Per Share (EPS)
 [NSE : SAKAR]  
            | Y-o-Y | -19.85 % | 
| 5 Yr CAGR | -4.40 % | 
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2024 | ₹5.37 | -19.85 | |
| Mar2023 | ₹6.70 | -24.46 | |
| Mar2022 | ₹8.87 | 29.68 | |
| Mar2021 | ₹6.84 | 6.38 | |
| Mar2020 | ₹6.43 | - | |
SAKAR HEALTHCARE  Return on Capital Employed (ROCE)
 [NSE : SAKAR]  
            | Y-o-Y | -17.09 % | 
| 5 Yr CAGR | -15.84 % | 
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2024 | 7.42% | -17.09 | |
| Mar2023 | 8.95% | -25.97 | |
| Mar2022 | 12.09% | -8.13 | |
| Mar2021 | 13.16% | -11.02 | |
| Mar2020 | 14.79% | - | |
SAKAR HEALTHCARE Share Price vs Sensex
| Current Share Price | : | ₹358.9 | 
| Current MarketCap | : | ₹ 796.6 Cr | 
| Updated EOD on | : | Oct 27,2025 | 
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year | 
| SAKAR HEALTHCARE | -1.7% | -2.4% | 10.7% | 
| SENSEX | 1% | 3.3% | 4.5% | 
SAKAR HEALTHCARE related INDICES
You may also like the below Video Courses
FAQ about SAKAR HEALTHCARE Financials
How the annual revenues of SAKAR HEALTHCARE have changed ?
The Revenues of SAKAR HEALTHCARE have increased by 4.00% YoY .
How the Earnings per Share (EPS) of SAKAR HEALTHCARE have changed?
The Earnings Per Share (EPS) of SAKAR HEALTHCARE has decreased by -19.85 % YoY .
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs
 
                     
                                     
                                     
                                    